Tsuduki E, Enomoto T, Yoshioka H, Henmi S, Hibino S, Azuma A, Yoshimura A, Takasaki Y, Fukuda Y, Kudoh S
Fourth Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Nihon Kokyuki Gakkai Zasshi. 1999 Oct;37(10):817-22.
We report a case of a 55-year-old man who had been treated for bronchial asthma diagnosed at the age of 51. One year following diagnosis, chest X-ray films disclosed nodular shadows. Biopsy specimens obtained by video-assisted thoracoscopic surgery were histopathologically identified as intrapulmonary lymph nodes. Three years after the initial diagnosis, the patient experienced sensory disturbance of the lower extremities, low-grade fever, and weight loss. At this point he was admitted to our hospital. On admission, physical examination and clinical investigations showed peripheral eosinophilia and signs of vasculitis. Specimens obtained by transbronchial lung biopsy and bronchoalveolar lavage showed strong evidence of tissue damage with infiltration of eosinophils but no evidence of necrotizing vasculitis or extra-vascular granuloma. Churg-Strauss syndrome (CSS) was diagnosed, and treatment was initiated with prednisolone at a dose of 60 mg/day. Except for the sensory disturbances in the lower extremities, after a few days of treatment the patient's symptoms subsided and his clinical data improved. This case was clinically important because pulmonary eosinophilic infiltration into vessel walls was confirmed a year after the diagnosis of bronchial asthma, and 2 years before the patient demonstrated signs of vasculitis. Further, it was a very rare case of CSS in which intrapulmonary lymph nodes had developed beneath the visceral pleura despite the absence of a history of heavy smoking, thus suggesting continuous stimulation by some as yet unknown antigen.
我们报告一例55岁男性患者,其在51岁时被诊断为支气管哮喘并接受治疗。诊断后一年,胸部X线片显示结节状阴影。通过电视辅助胸腔镜手术获取的活检标本经组织病理学鉴定为肺内淋巴结。初始诊断三年后,患者出现下肢感觉障碍、低热和体重减轻。此时他被收入我院。入院时,体格检查和临床检查显示外周嗜酸性粒细胞增多和血管炎体征。经支气管肺活检和支气管肺泡灌洗获取的标本显示有强烈的组织损伤证据,伴有嗜酸性粒细胞浸润,但无坏死性血管炎或血管外肉芽肿证据。诊断为变应性肉芽肿性血管炎(CSS),开始使用泼尼松龙治疗,剂量为60mg/天。除下肢感觉障碍外,治疗几天后患者症状消退,临床数据改善。该病例具有临床重要性,因为在支气管哮喘诊断一年后,且在患者出现血管炎体征两年前,证实了肺嗜酸性粒细胞浸润血管壁。此外,这是一例非常罕见的CSS病例,尽管没有大量吸烟史,但在内脏胸膜下出现了肺内淋巴结,提示受到某种未知抗原的持续刺激。